Walgreens reaches $80 million settlement over painkillers
The nations largest pharmacy retailer has reached a record-breaking settlement with the Drug Enforcement Administration (DEA).
June 12, 2013 at 07:34 AM
5 minute read
The original version of this story was published on Law.com
The nation's largest pharmacy retailer has reached a record-breaking settlement with the Drug Enforcement Administration (DEA).
Yesterday, the DEA announced that Walgreen Co. has agreed to pay $80 million in civil penalties to resolve the agency's allegations that it violated federal prescription painkiller distribution rules under the Controlled Substances Act. The fine is the largest ever of its kind.
According to the DEA, Walgreens committed an “unprecedented” number of record-keeping and dispensing violations by allowing highly addictive controlled substances, such as oxycodone, to be distributed to abusers and illegally resold. Walgreens admitted that it failed to uphold its obligations as a DEA registrant, which requires it to flag suspicious prescription painkiller sales.
“National pharmaceutical chains are not exempt from following the law,” Mark Trouville, special agent in charge in the DEA's Miami field division, said in a statement. “All DEA registrants will be held accountable when they violate the law and threaten public health and safety.”
As part of the agreement, six Florida Walgreens and a Florida distribution center are banned from dispensing various controlled substances for two years. The DEA considers Florida the epicenter of illegal prescription drug sales.
Walgreens also agreed to enhance training and compliance programs and set up a special internal department to prevent future similar violations.
“As the largest pharmacy chain in the U.S., we are fully committed to doing our part to prevent prescription drug abuse,” Kermit Crawford, president of pharmacy, health and wellness at Walgreens, said in a statement.
Read Thomson Reuters and the Wall Street Journal for more information.
For more InsideCounsel stories about the pharmaceutical industry, read:
The nation's largest pharmacy retailer has reached a record-breaking settlement with the Drug Enforcement Administration (DEA).
Yesterday, the DEA announced that
According to the DEA, Walgreens committed an “unprecedented” number of record-keeping and dispensing violations by allowing highly addictive controlled substances, such as oxycodone, to be distributed to abusers and illegally resold. Walgreens admitted that it failed to uphold its obligations as a DEA registrant, which requires it to flag suspicious prescription painkiller sales.
“National pharmaceutical chains are not exempt from following the law,” Mark Trouville, special agent in charge in the DEA's Miami field division, said in a statement. “All DEA registrants will be held accountable when they violate the law and threaten public health and safety.”
As part of the agreement, six Florida Walgreens and a Florida distribution center are banned from dispensing various controlled substances for two years. The DEA considers Florida the epicenter of illegal prescription drug sales.
Walgreens also agreed to enhance training and compliance programs and set up a special internal department to prevent future similar violations.
“As the largest pharmacy chain in the U.S., we are fully committed to doing our part to prevent prescription drug abuse,” Kermit Crawford, president of pharmacy, health and wellness at Walgreens, said in a statement.
Read Thomson Reuters and the Wall Street Journal for more information.
For more InsideCounsel stories about the pharmaceutical industry, read:
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllLululemon Faces Legal Fire Over Its DEI Program After Bias Complaints Surface
3 minute readOld Laws, New Tricks: Lawyers Using Patchwork of Creative Legal Theories to Target New Tech
Lawsuit Against Amazon Could Reshape E-Commerce Landscape
Trending Stories
- 1Gibson Dunn Sued By Crypto Client After Lateral Hire Causes Conflict of Interest
- 2Trump's Solicitor General Expected to 'Flip' Prelogar's Positions at Supreme Court
- 3Pharmacy Lawyers See Promise in NY Regulator's Curbs on PBM Industry
- 4Outgoing USPTO Director Kathi Vidal: ‘We All Want the Country to Be in a Better Place’
- 5Supreme Court Will Review Constitutionality Of FCC's Universal Service Fund
Who Got The Work
Michael G. Bongiorno, Andrew Scott Dulberg and Elizabeth E. Driscoll from Wilmer Cutler Pickering Hale and Dorr have stepped in to represent Symbotic Inc., an A.I.-enabled technology platform that focuses on increasing supply chain efficiency, and other defendants in a pending shareholder derivative lawsuit. The case, filed Oct. 2 in Massachusetts District Court by the Brown Law Firm on behalf of Stephen Austen, accuses certain officers and directors of misleading investors in regard to Symbotic's potential for margin growth by failing to disclose that the company was not equipped to timely deploy its systems or manage expenses through project delays. The case, assigned to U.S. District Judge Nathaniel M. Gorton, is 1:24-cv-12522, Austen v. Cohen et al.
Who Got The Work
Edmund Polubinski and Marie Killmond of Davis Polk & Wardwell have entered appearances for data platform software development company MongoDB and other defendants in a pending shareholder derivative lawsuit. The action, filed Oct. 7 in New York Southern District Court by the Brown Law Firm, accuses the company's directors and/or officers of falsely expressing confidence in the company’s restructuring of its sales incentive plan and downplaying the severity of decreases in its upfront commitments. The case is 1:24-cv-07594, Roy v. Ittycheria et al.
Who Got The Work
Amy O. Bruchs and Kurt F. Ellison of Michael Best & Friedrich have entered appearances for Epic Systems Corp. in a pending employment discrimination lawsuit. The suit was filed Sept. 7 in Wisconsin Western District Court by Levine Eisberner LLC and Siri & Glimstad on behalf of a project manager who claims that he was wrongfully terminated after applying for a religious exemption to the defendant's COVID-19 vaccine mandate. The case, assigned to U.S. Magistrate Judge Anita Marie Boor, is 3:24-cv-00630, Secker, Nathan v. Epic Systems Corporation.
Who Got The Work
David X. Sullivan, Thomas J. Finn and Gregory A. Hall from McCarter & English have entered appearances for Sunrun Installation Services in a pending civil rights lawsuit. The complaint was filed Sept. 4 in Connecticut District Court by attorney Robert M. Berke on behalf of former employee George Edward Steins, who was arrested and charged with employing an unregistered home improvement salesperson. The complaint alleges that had Sunrun informed the Connecticut Department of Consumer Protection that the plaintiff's employment had ended in 2017 and that he no longer held Sunrun's home improvement contractor license, he would not have been hit with charges, which were dismissed in May 2024. The case, assigned to U.S. District Judge Jeffrey A. Meyer, is 3:24-cv-01423, Steins v. Sunrun, Inc. et al.
Who Got The Work
Greenberg Traurig shareholder Joshua L. Raskin has entered an appearance for boohoo.com UK Ltd. in a pending patent infringement lawsuit. The suit, filed Sept. 3 in Texas Eastern District Court by Rozier Hardt McDonough on behalf of Alto Dynamics, asserts five patents related to an online shopping platform. The case, assigned to U.S. District Judge Rodney Gilstrap, is 2:24-cv-00719, Alto Dynamics, LLC v. boohoo.com UK Limited.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250